These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17895942)

  • 61. A randomized trial of delayed extubation for the reduction of reintubation in extremely preterm infants.
    Danan C; Durrmeyer X; Brochard L; Decobert F; Benani M; Dassieu G
    Pediatr Pulmonol; 2008 Feb; 43(2):117-24. PubMed ID: 18092355
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002.
    Smith VC; Zupancic JA; McCormick MC; Croen LA; Greene J; Escobar GJ; Richardson DK
    J Pediatr; 2005 Apr; 146(4):469-73. PubMed ID: 15812448
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidemiology of bronchopulmonary dysplasia.
    Jensen EA; Schmidt B
    Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):145-57. PubMed ID: 24639412
    [TBL] [Abstract][Full Text] [Related]  

  • 64. G protein-coupled receptor for asthma susceptibility associates with respiratory distress syndrome.
    Pulkkinen V; Haataja R; Hannelius U; Helve O; Pitkänen OM; Karikoski R; Rehn M; Marttila R; Lindgren CM; Hästbacka J; Andersson S; Kere J; Hallman M; Laitinen T
    Ann Med; 2006; 38(5):357-66. PubMed ID: 16938805
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dysplasia: a review.
    Bokodi G; Treszl A; Kovács L; Tulassay T; Vásárhelyi B
    Pediatr Pulmonol; 2007 Oct; 42(10):952-61. PubMed ID: 17726703
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pitfalls, problems, and progress in bronchopulmonary dysplasia.
    Bhandari A; Bhandari V
    Pediatrics; 2009 Jun; 123(6):1562-73. PubMed ID: 19482769
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Toxicity of oxygen and (Cu) superoxide dismutase and (Mn) superoxide dismutase in newborn infants with respiratory distress. Preliminary results].
    Lindenbaum A; Magny JF; Abella A; Chalas J; Baret A; Dehan M
    Pathol Biol (Paris); 1987 Feb; 35(2):173-6. PubMed ID: 3550627
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia.
    Reuter SD; O'Donovan DJ; Hegemier SE; Smith EO; Heird WC; Fernandes CJ
    J Perinatol; 2007 May; 27(5):303-6. PubMed ID: 17363910
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Bronchopulmonary dysplasia in very low birth weight infants].
    Pezzani FM; Montali S; Lazzerini M; Bini F
    Pediatr Med Chir; 1982; 4(5):497-500. PubMed ID: 6927345
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.
    Aghai ZH; Faqiri S; Saslow JG; Nakhla T; Farhath S; Kumar A; Eydelman R; Strande L; Stahl G; Leone P; Bhandari V
    J Perinatol; 2008 Feb; 28(2):149-55. PubMed ID: 18033304
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Management of infants with bronchopulmonary dysplasia in North America.
    Bancalari E; Wilson-Costello D; Iben SC
    Early Hum Dev; 2005 Feb; 81(2):171-9. PubMed ID: 15748972
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lung protective ventilatory strategies in very low birth weight infants.
    Ramanathan R; Sardesai S
    J Perinatol; 2008 May; 28 Suppl 1():S41-6. PubMed ID: 18446177
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment.
    Hwang JS; Rehan VK
    Lung; 2018 Apr; 196(2):129-138. PubMed ID: 29374791
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic analysis of the dystroglycan gene in bronchopulmonary dysplasia affected premature newborns.
    Concolino P; Capoluongo E; Santonocito C; Vento G; Tana M; Romagnoli C; Zuppi C; Ameglio F; Brancaccio A; Sciandra F
    Clin Chim Acta; 2007 Mar; 378(1-2):164-7. PubMed ID: 17196572
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Eosinophil activation in preterm infants with lung disease.
    Broström EB; Katz-Salamon M; Lundahl J; Halldén G; Winbladh B
    Acta Paediatr; 2007 Jan; 96(1):23-8. PubMed ID: 17187598
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic lung disease of prematurity: long-term respiratory outcome.
    El Mazloum D; Moschino L; Bozzetto S; Baraldi E
    Neonatology; 2014; 105(4):352-6. PubMed ID: 24931329
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD.
    Fukunaga S; Ichiyama T; Maeba S; Okuda M; Nakata M; Sugino N; Furukawa S
    Pediatr Pulmonol; 2009 Mar; 44(3):267-72. PubMed ID: 19205055
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bronchopulmonary Dysplasia Within and Beyond the Neonatal Unit.
    Khetan R; Hurley M; Spencer S; Bhatt JM
    Adv Neonatal Care; 2016 Feb; 16(1):17-25;quiz E1-2. PubMed ID: 26734814
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnosis and management of bronchopulmonary dysplasia.
    Gilfillan M; Bhandari A; Bhandari V
    BMJ; 2021 Oct; 375():n1974. PubMed ID: 34670756
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
    Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
    Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.